AbbVie halts late-stage trial for lung cancer drug Rova-T

AbbVie Inc said on Wednesday it had halted enrollment for a late stage trial of Rova-T as a second-line therapy for advanced small-cell lung cancer, following recommendations made by an independent data monitoring committee.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/6L-XhfgRrLA/abbvie-halts-late-stage-trial-for-lung-cancer-drug-rova-t-idINKBN1O42QK

Related Posts